.png)
Medable Events
DPHARM
Boston, MA
Meet us the 13th annual DPHARM® conference on September 20-22 at the Westin Copley Place in Boston, MA for exciting discussions with innovative thought leaders aroound the latest innovations to modernize clinical trials.
Upcoming Events
SCOPE Europe
Meet with us at SCOPE-EU. This event brings together leaders from large, mid-sized, and small pharma, specialty pharma, biotech, CROs, vendors, and academic research centers who come together to share best practices and discuss the new era of decentralized, analytics-driven and patient-centric trials
DTRA
Join the DTRA member community as we gather leading visionaries in decentralized research and clinical trials in our annual event to share ideas, develop lasting connections, and create new bonds over our shared mission to make patient-focused research accessible to everyone.
CNS Summit
The Summit brings together a curated group of top decision makers from pharma, biotech, CROs, investigator sites, patient advocacy groups, investors and other stakeholders. Your event registration also provides access to our year-round programming and community activities.
Upcoming webinar
On-Demand Webinars
Strategies for implementing eConsent across the European regulatory landscape
Camila Matheny, EVP of DCT Offerings at Medable and Caroline Beaufour, PharmD, Ph.D., Innovation Lead, Clinical Development Support at Servier, dive into the intricacies of implementing electronic informed consent (eConsent) in clinical trials within the complex regulatory landscape of European countries.
DCT Digital Week: Creating the Digital Foundation for Scale in Clinical Development
Learn how sponsors and CROs can improve their clinical trial conduct by developing new strategies that create sustainable, repeatable, and effective clinical conduct.
eCOA Digital Week: An honest assessment of eCOAs from a site perspective
Joe Dustin, VP/GM of eCOA and Annie Hesslewood, Site & Patient adoption lead at Medable host an open discussion with a panel of sites and CRAs to provide a candid assessment of how upcoming changes in the eCOA landscape can reduce burden on participants and sites to maximize the chance of success in clinical trials.